Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Nitazoxanide and Probiotics for the Treatment of Recurrent Clostridium difficile Infection in a Peritoneal Dialysis Patient
Southern Medical Journal, 07/02/09
Yangco BG et al. - A 58-year-old woman was admitted with hypotension, nausea and vomiting attributed to metronidazole therapy for CDI, her third CDI treatment regimen in 3 months. During her admission, the patient developed CDI and was started on a 6-week regimen of nitazoxanide and probiotics to assist in re-establishing the colonic flora. The regimen was well tolerated and the patient remained disease free at follow up, four months later.
Related Articles
The Anti-Hepatitis C Agent Nitazoxanide Induces Phosphorylation of Eukaryotic Initiation Factor 2alpha Via Protein Kinase Activated by Double-Stranded RNA Activation
Gastroenterology, 10/29/09
Relevance Score: 80%
Today in GI Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Test-and-treat strategy for Helicobacter pylori (HP) infection in older patients
Archives of Gerontology and Geriatrics, 12/18/09
Air cavitogram as investigative modality for Amoebic Liver Abscess
The Internet Journal of Gastroenterology, 12/18/09
Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after
BMC Infectious Diseases, 12/18/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/18/09
New modalities and paradigms for sedation: new sedation agents
Techniques in Gastrointestinal Endoscopy , 12/18/09
No beneficial effects of amantadine in treatment of chronic hepatitis C patients
Digestive and Liver Diseases, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


